Author:
Millot F,Esperou H,Bordigoni P,Dalle J-H,Michallet M,Michel G,Bourhis J L,Kuenz M,Blaise D,Garban F,Plouvier E,Rome A,Guilhot J,Guilhot F
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference29 articles.
1. Guilhot F, Chastang C, Michallet M et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. N Engl J Med 1997; 337: 223–229.
2. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Long term follow-up of the Italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia. Blood 1998; 92: 1541–1548.
3. Druker B, Talpaz M, Resta D et al. Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.
4. Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–652.
5. Silver RT, Woolf SH, Hehlmann R et al. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood 1999; 94: 1517–1536.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献